Cagrilintide Amylin Analog Vial For Appetite Suppression Drug Development Study
TDS 66 Inquiries
1415456-99-3
Cosmetics Grade
99%
guangzhou
chunqiao
5mg10vials,10 Vials per kit
Yes
2026-11-15
peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
CertificatesBasic Info-
Product Name:
Cagrilintide
Other Name:Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide
CAS No.:1415456-99-3
Molecular Formula:C194H312N54O59S2
Molecular Weight:0
EC Number:206-141-6
Color/Form:White to off-white
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Unit 1-B2141, 19B-F1, 81-1 Nonglinxia Road, Yuexiu District, Guangzhou, China
-
Payment Terms:
100% TT in advance
-
Year of Establishment:
2026
-
-
Inquiry History66 Inquiries
Country Product Purchase Quantity Date Posted
United States
Cagrilintide
10 MG Sep 23, 2026
United States
Cagrilintide
25 MG Aug 31, 2026
United States
Cagrlintide
1 MT Jul 31, 2026
United Kingdom
cagrilintrude
20 MG Jul 21, 2026
United States
Cagrilintide
1 KG Jul 17, 2026
United States
Cagrilintide
30 MG May 26, 2026
United Kingdom
CAGRILLINTED
10 May 3, 2026
Hongkong, China
Cagrilintide
100 MG Apr 22, 2026
United Kingdom
Cagrilintide
1 KG Apr 14, 2026
Ireland
Cagrilintide
10 PCS Apr 14, 2026
United States
Cargrilintide
10 MG Mar 19, 2026
United Kingdom
cagrilintide
10 MG Feb 18, 2026
China
CagriSema cagrilintide 2.5mg+Samaglutide2.5mg
10 MG Jan 26, 2026
South Korea
Cagrilintide
500 MG Jan 21, 2026
Pakistan
cagrilintide
1 KG Dec 26, 2025
United States
Cagrilintide
20 MG Dec 19, 2025
United Kingdom
Cagrilintide
100 MG Dec 10, 2025
Canada
All peptides
1001 MT Nov 12, 2025
United States
Cagrilintide
10 MG Oct 13, 2024
United States
Cagrilintide
1 MG Jun 3, 2024 Post an enquiry for this product
More from this Seller
-
-
-
IGF1-dfs White Powder For Research Purpose Only Pharmaceutical Grade
Pharmaceutical Grade / 99%
$45-55/MT FOB
-
-
-
-
PNC-27 Anticancer 5mg Vial For Tumor Cell Apoptosis Therapeutic Development
Cosmetics Grade / 99%
$100/UNIT FOB
-
-
-
-
Products -Retatrutid- Purity up to 99% peptide-
Pharmaceutical Grade / 99%
-
-
-
-
Survodutide Dual Glucagon GLP-1 Vial For Fat Loss Clinical Research Application
Cosmetics Grade / 99%
$150/UNIT FOB
-
-
-
-
Cibinetide EPO Derived Compound For Tissue Protection Therapeutic Evaluation
Cosmetics Grade / 99%
$80/UNIT FOB
-
-
-
-
Mazdutide Multi Receptor Agonist Vial For Weight Loss Drug Development Trial
Cosmetics Grade / 99%
$160/UNIT FOB
-
